Lophius Biosciences GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lophius Biosciences GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10575
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modulation to evaluate the functionality of cell mediated immunity. Its T-track CMV is a diagnostic test to measure CMV-specific cell mediated immunity. Lophius provides T cell tools such as ELISpot kits, T cell stimulants, and custom ELISpot kit. The company offers services including antigen selection, optimization, immune assay development and therapy monitoring. It markets its products through its specialized marketing and distribution partners in Germany, Spain, the Netherlands, Belgium, Luxemburg and Korea. Lophius is headquartered in Regensburg, Germany.

Lophius Biosciences GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 11
Lophius Biosciences Raises USD4.66 Million in Venture Financing 12
Lophius Biosciences Raises Funds through Venture Financing 13
Lophius Biosciences Raises US$2.8 Million In Venture Financing 14
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 15
Lophius Biosciences GmbH – Key Competitors 16
Lophius Biosciences GmbH – Key Employees 17
Lophius Biosciences GmbH – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Mar 22, 2017: Lophius Biosciences Appoints Robert J. Silverman as Supervisory Board Member 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 11
Lophius Biosciences Raises USD4.66 Million in Venture Financing 12
Lophius Biosciences Raises Funds through Venture Financing 13
Lophius Biosciences Raises US$2.8 Million In Venture Financing 14
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 15
Lophius Biosciences GmbH, Key Competitors 16
Lophius Biosciences GmbH, Key Employees 17

List of Figures
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Lophius Biosciences GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hays plc:企業の戦略・SWOT・財務情報
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Daqo New Energy Corp (DQ):電力:M&Aディール及び事業提携情報
    Summary Daqo New Energy Corp (Daqo Cayman) is a manufacturer of polysilicon and solar wafers. Through tolling agreements, the company also offers wafer original equipment manufacturer (OEM) services to external customers. It sells its products to solar cell and solar module manufacturers. Daqo Cayma …
  • Penn Virginia Corporation (PVAC)-石油・ガス分野:企業M&A・提携分析
    Summary Penn Virginia Corporation (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company carries out its operations in various domestic onshore regions of the US, primarily in the Eagle Ford Shale …
  • Celon Pharma SA (CLN)-製薬・医療分野:企業M&A・提携分析
    Summary Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutic …
  • Nippon Shikizai Inc.:企業の戦略・SWOT・財務情報
    Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report Summary Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • Babcock & Wilcox Enterprises Inc (BW):電力:M&Aディール及び事業提携情報
    Summary Babcock & Wilcox Enterprises, Inc. (Babcock & Wilcox) is a provider of technology-based advanced fossil and renewable power generation and environmental equipment. The company offers a range of biomass-fired boilers products such as supercritical boiler, waste-to-energy boilers, heat recover …
  • Ca Immobilien Anlagen Ag
    Ca Immobilien Anlagen Ag - Strategy, SWOT and Corporate Finance Report Summary Ca Immobilien Anlagen Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • EV Energy Partners LP:企業のM&A・事業提携・投資動向
    EV Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EV Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Accu-Break Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • Recylex SA:企業の戦略・SWOT・財務分析
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Uni-President Enterprises Corp:企業の戦略・SWOT・財務情報
    Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report Summary Uni-President Enterprises Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis) formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Ibersol S.G.P.S., S.A.
    Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report Summary Ibersol S.G.P.S., S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kernel Holding SA:企業の戦略・SWOT・財務情報
    Kernel Holding SA - Strategy, SWOT and Corporate Finance Report Summary Kernel Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Petroleos Mexicanos-石油・ガス分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • Medical Research Council-製薬・医療分野:企業M&A・提携分析
    Summary Medical Research Council (MRC) is a human health research council that offers medical research programs. The council offers research across medical sciences services, universities and hospitals, centers and institutes. It provides data management, research platform, tools and facilities to g …
  • University of Texas Southwestern Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …
  • Hyundai Motor Co (005380):企業の財務・戦略的SWOT分析
    Hyundai Motor Co (005380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆